EU SCIENTIFIC NETWORK TO FOCUS ON PHARMACEUTICAL PROJECTS

BY KEITH NUTHALL

THE EUROPEAN Union (EU)-coordinated COST network of researchers has approved 25 new projects, with key studies focusing on medicine. COST has appealed for research groups worldwide to participate. The subjects include investigating new drugs for neglected diseases; translating genomic and epigenetic studies of myelodysplastic syndromes and acute myeloid leukemia; protozoan parasites; and histocompatibility.
* http://www.cost.esf.org/

ENDS


Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.